498P Impact of estrogen receptor expression on real-world effectiveness of first-line ET+CDK4/6i in patients with HR+/HER2- advanced BC.

Saved in:
Bibliographic Details
Title: 498P Impact of estrogen receptor expression on real-world effectiveness of first-line ET+CDK4/6i in patients with HR+/HER2- advanced BC.
Authors: Vernieri, C.1 (AUTHOR), Dieci, M.V.2 (AUTHOR), Caputo, R.3 (AUTHOR), Vigneri, P.4 (AUTHOR), Giuliano, M.5 (AUTHOR), Curigliano, G.6 (AUTHOR), Toss, A.7 (AUTHOR), Botticelli, A.8 (AUTHOR), Pedersini, R.9 (AUTHOR), Cinieri, S.10 (AUTHOR), Lambertini, M.11 (AUTHOR), Tagliaferri, B.12 (AUTHOR), Rizzo, G.13 (AUTHOR), Sirico, M.14 (AUTHOR), Giordano, M.15 (AUTHOR), Gerratana, L.16 (AUTHOR), Meattini, I.17 (AUTHOR), Piras, M.18 (AUTHOR), Fabi, A.19 (AUTHOR), Ligorio, F.1 (AUTHOR)
Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS408-S409. 2p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2025.08.921